138 related articles for article (PubMed ID: 15545894)
1. FDG PET and gallium scintigraphy for diagnosis of an advanced jejunal adenocarcinoma with distant metastases.
Yamaura G; Yoshioka T; Kubota K; Yamaguchi K; Iwata R; Abe T; Kitagawa Y; Kanamaru R; Fukuda H; Ishioka C
Clin Nucl Med; 2004 Dec; 29(12):825-7. PubMed ID: 15545894
[No Abstract] [Full Text] [Related]
2. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
[TBL] [Abstract][Full Text] [Related]
3. [Utility of PET-18FDG in primary tumor site in a patient with cerebral metastases].
Suárez Fernández JP; Serna Macías JA; Domínguez Grande ML; Liaño H; Pozo MA; Maldonado Suárez A
Rev Esp Med Nucl; 2005; 24(4):253. PubMed ID: 16122410
[No Abstract] [Full Text] [Related]
4. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
5. Superiority of F-18 FDG PET imaging for detection of a pheochromocytoma.
Sood R; Story A; Rossleigh MA; Haindl W; Guille J; Pillai D
Clin Nucl Med; 2006 Jan; 31(1):13-5. PubMed ID: 16374114
[No Abstract] [Full Text] [Related]
6. Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy.
Xiu Y; Yu JQ; Cheng E; Kumar R; Alavi A; Zhuang H
Clin Nucl Med; 2005 Mar; 30(3):193-5. PubMed ID: 15722828
[No Abstract] [Full Text] [Related]
7. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
Wartski M; Le Stanc E; Gontier E; Vilain D; Banal A; Tainturier C; Pecking AP; Alberini JL
Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
[TBL] [Abstract][Full Text] [Related]
8. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.
Rusthoven KE; Koshy M; Paulino AC
Cancer; 2004 Dec; 101(11):2641-9. PubMed ID: 15517576
[TBL] [Abstract][Full Text] [Related]
9. [(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
Hu M; Li MH; Kong L; Liu NB; Yang GR; Yu JM
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):699-701. PubMed ID: 19173915
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies.
Basu S; Alavi A
Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):427-8. PubMed ID: 17195072
[No Abstract] [Full Text] [Related]
11. Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Linke R; Schroeder M; Helmberger T; Voltz R
Neurology; 2004 Jul; 63(2):282-6. PubMed ID: 15277621
[TBL] [Abstract][Full Text] [Related]
12. F-18 FDG PET and Ga-67 scintigraphy in a case of fever of unknown origin with underlying cutaneous diffuse large B-Cell lymphoma.
Hsieh HJ; Lin SH; Chu YK; Chang CP; Liu RS
Clin Nucl Med; 2004 Dec; 29(12):859-60. PubMed ID: 15545909
[No Abstract] [Full Text] [Related]
13. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin.
Blockmans D; Knockaert D; Maes A; De Caestecker J; Stroobants S; Bobbaers H; Mortelmans L
Clin Infect Dis; 2001 Jan; 32(2):191-6. PubMed ID: 11170907
[TBL] [Abstract][Full Text] [Related]
14. Metastatic hepatic lesions are detected better by delayed imaging with prolonged emission time.
Chen YK; Kao CH
Clin Nucl Med; 2005 Jun; 30(6):455-6. PubMed ID: 15891311
[No Abstract] [Full Text] [Related]
15. FDG-PET imaging in duodenal cancer.
Watanabe N; Hayashi S; Kato H; Shimizu M; Kamisaki Y; Noguchi K; Kishida M; Matsunari I; Hisada K; Seto H
Ann Nucl Med; 2004 Jun; 18(4):351-3. PubMed ID: 15359930
[TBL] [Abstract][Full Text] [Related]
16. PET detection of solitary distant skeletal muscle metastasis of esophageal adenocarcinoma.
Wu G; Bybel B; Brunken R; Lin H; Neumann D
Clin Nucl Med; 2005 May; 30(5):335-7. PubMed ID: 15827406
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
[TBL] [Abstract][Full Text] [Related]
18. Diaphragm and Laryngeal FDG Uptake With Hiccups.
Srivastava MK; Jain AS; Panneer V; Muthukrishnan I; Simon S
Clin Nucl Med; 2015 Nov; 40(11):e514-5. PubMed ID: 26204217
[TBL] [Abstract][Full Text] [Related]
19. Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma.
Aydin A; Yu JQ; Zhuang H; Alavi A
Clin Nucl Med; 2005 Sep; 30(9):606-7. PubMed ID: 16100478
[TBL] [Abstract][Full Text] [Related]
20. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
AAssar OS; Fischbein NJ; Caputo GR; Kaplan MJ; Price DC; Singer MI; Dillon WP; Hawkins RA
Radiology; 1999 Jan; 210(1):177-81. PubMed ID: 9885604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
